share_log
Breakings ·  Aug 2 20:00
Agilent Receives FDA Approval for Mage-a4 Ihc 1F9 Pharmdx as a Diagnostic Tool for Use With Newly Approved Tcr T-Cell Therapy
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment